Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah A Zarin

Showing results (11-20 of 67) with videos related to

Pageof 7
Sort By:
Annals of Internal Medicine|January 19, 2011
The effect of funding source on outcome reporting among drug trialsDeborah A Zarin, Tony Tse
Science (New York, N.Y.)|March 8, 2008
Medicine. Moving toward transparency of clinical trialsDeborah A Zarin, Tony Tse
Chest|February 17, 2007
Registering a clinical trial in ClinicalTrials.govDeborah A Zarin, Alla Keselman
Plos Medicine|January 20, 2016
Sharing Individual Participant Data (IPD) within the Context of the Trial Reporting System (TRS)Deborah A Zarin, Tony Tse
Clinical Trials (London, England)|December 16, 2020
Lack of harmonization of coronavirus disease ordinal scalesDeborah A Zarin, Stephen Rosenfeld
The New England Journal of Medicine|January 12, 2007
Salvation by registrationJeffrey M Drazen, Deborah A Zarin
Pediatrics|September 1, 2021
Monitoring the Pediatric Clinical Trials EnterpriseRobert M Califf, Deborah A Zarin
Clinical Therapeutics|March 1, 2022
Reporting of Clinical Trial Results: Aligning Incentives and Requirements to Do the Right ThingDeborah A Zarin, Harry P Selker
JAMA Internal Medicine|May 24, 2021
Trial Reporting and the Clinical Trials EnterpriseDeborah A Zarin, Robert M Califf
JAMA|March 6, 2014
Federal human research oversight of clinical trials in the United StatesDeborah A Zarin, Tony Tse, Jerry Menikoff
Pageof 7

Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Annals of Internal Medicine|January 19, 2011
The effect of funding source on outcome reporting among drug trialsDeborah A Zarin, Tony Tse
Science (New York, N.Y.)|March 8, 2008
Medicine. Moving toward transparency of clinical trialsDeborah A Zarin, Tony Tse
Chest|February 17, 2007
Registering a clinical trial in ClinicalTrials.govDeborah A Zarin, Alla Keselman
Plos Medicine|January 20, 2016
Sharing Individual Participant Data (IPD) within the Context of the Trial Reporting System (TRS)Deborah A Zarin, Tony Tse
Clinical Trials (London, England)|December 16, 2020
Lack of harmonization of coronavirus disease ordinal scalesDeborah A Zarin, Stephen Rosenfeld
The New England Journal of Medicine|January 12, 2007
Salvation by registrationJeffrey M Drazen, Deborah A Zarin
Pediatrics|September 1, 2021
Monitoring the Pediatric Clinical Trials EnterpriseRobert M Califf, Deborah A Zarin
Clinical Therapeutics|March 1, 2022
Reporting of Clinical Trial Results: Aligning Incentives and Requirements to Do the Right ThingDeborah A Zarin, Harry P Selker
JAMA Internal Medicine|May 24, 2021
Trial Reporting and the Clinical Trials EnterpriseDeborah A Zarin, Robert M Califf
JAMA|March 6, 2014
Federal human research oversight of clinical trials in the United StatesDeborah A Zarin, Tony Tse, Jerry Menikoff
Pageof 7